CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-01 | Knowles Julius Director | Sale | −1,531 | $52.72 | $81K | 380,170 |
| 2021-06-01 | Knowles Julius Director | Sale | −633 | $53.77 | $34K | 567,018 |
| 2021-06-01 | Knowles Julius Director | Sale | −414 | $53.77 | $22K | 379,756 |
| 2021-06-01 | Knowles Julius Director | Sale | −46 | $54.62 | $3K | 566,972 |
| 2021-06-01 | Knowles Julius Director | Sale | −30 | $54.62 | $2K | 379,726 |
| 2021-06-01 | Nussbaum Ran Director | Grant or award · Stock Option (right to buy) | +8,293 | 8,293 | ||
| 2021-06-01 | Knowles Julius Director | Grant or award · Stock Option (right to buy) | +8,293 | 8,293 | ||
| 2021-06-01 | Kariv Tomer Director | Grant or award · Stock Option (right to buy) | +8,293 | 8,293 | ||
| 2021-06-01 | GRAY MARY ANN Director | Grant or award · Stock Option (right to buy) | +8,293 | 8,293 | ||
| 2021-06-01 | Farzan Nima Director | Grant or award · Stock Option (right to buy) | +8,293 | 8,293 | ||
| 2021-06-01 | GORDON CARL L Director | Grant or award · Stock Option (right to buy) | +8,293 | 8,293 | ||
| 2021-05-13 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +6,220 | $0.11 | $684 | 77,407 |
| 2021-05-13 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +500 | $0.30 | $150 | 77,907 |
| 2021-05-13 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −6,220 | 0 | ||
| 2021-05-13 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −500 | 7,793 | ||
| 2021-05-11 | Ordonez Claudia Chief Medical Officer | Exercise or conversion | +1,000 | $0.48 | $480 | 1,000 |
| 2021-05-11 | Ordonez Claudia Chief Medical Officer | Sale | −1,000 | $50.15 | $50K | 0 |
| 2021-05-11 | Ordonez Claudia Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,000 | 99,211 | ||
| 2021-05-11 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +2,650 | $0.30 | $795 | 73,837 |
| 2021-05-11 | Lachey Jennifer Chief Scientific Officer | Sale | −2,650 | $50.00 | $133K | 71,187 |
Page 20 of 36 · 707 trades